Institutional investors purchased a net $1.0 million shares of XNPT during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 79.70% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAMBER CAPITAL MANAGEMENT LLC Bought 809.9 Thousand shares of Xenoport Inc
MILLENNIUM MANAGEMENT LLC Bought 712.1 Thousand shares of Xenoport Inc